Crispr Therapeutics shares owned by Front Row Advisors
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Front Row Advisors
from 13F filings
Historical chart of Front Row Advisors investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Front Row Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Front Row Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $8.7k | 134 | 64.81 |
| 2025-06-30 | $5.6k | 116 | 48.64 |
| 2025-03-31 | $3.9k | 116 | 34.03 |
| 2024-12-31 | $4.6k | 116 | 39.36 |
| 2024-09-30 | $5.5k | 116 | 46.98 |
| 2024-06-30 | $6.3k | 116 | 54.01 |
| 2024-03-31 | $7.9k | 116 | 68.16 |
| 2023-12-31 | $7.3k | 116 | 62.60 |
| 2023-09-30 | $38k | 836 | 45.39 |
| 2023-06-30 | $936k | 17k | 56.16 |
| 2023-03-31 | $1.7k | 781 | 2.21 |
| 2022-12-31 | $709k | 17k | 40.64 |
| 2022-09-30 | $1.2M | 19k | 65.35 |
| 2022-06-30 | $1.2M | 19k | 60.76 |
| 2022-03-31 | $1.2M | 19k | 62.79 |
| 2021-12-31 | $1.4M | 19k | 75.76 |
| 2021-09-30 | $2.0M | 18k | 111.96 |
| 2021-06-30 | $2.0M | 18k | 116.81 |
| 2021-03-31 | $2.0M | 17k | 121.83 |
| 2020-12-31 | $2.4M | 16k | 153.11 |
| 2020-09-30 | $2.0M | 16k | 121.56 |
| 2020-06-30 | $1.2M | 17k | 73.52 |
| 2020-03-31 | $825k | 17k | 49.19 |
| 2019-12-31 | $3.0k | 50 | 60.00 |
| 2019-09-30 | $2.0k | 50 | 40.00 |
| 2019-06-30 | $2.0k | 50 | 40.00 |
| 2019-03-31 | $2.0k | 50 | 40.00 |